Epigallocatechin-3-Gallate Improves Facial Dysmorphology Associated with Down Syndrome
John M. Starbuck, Sergi Llambrich, Ruben González, Julia Albaigès, Anna Sarlé, Jens Wouters, Alejandro González, Xavier Sevillano, James Sharpe, Rafael de La Torre, Mara Dierssen, Greetje Vande Velde, Neus Martínez-Abadías
This study shows EGCG treatment improves facial dysmorphology in DS mouse models and humans but warns against non-prescribed use due to variable outcomes.
bioRxiv · Mar 5, 2018 · PreprintPathology